StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report report published on Thursday morning. The brokerage issued a hold rating on the stock.

Milestone Scientific Price Performance

Shares of NYSE:MLSS opened at $0.65 on Thursday. The business has a 50-day moving average of $0.65 and a two-hundred day moving average of $0.69. The firm has a market capitalization of $49.79 million, a PE ratio of -6.50 and a beta of 0.94. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.35.

Milestone Scientific (NYSE:MLSS) last issued its earnings results on Friday, March 29th. The company reported ($0.03) earnings per share (EPS) for the quarter. Milestone Scientific had a negative return on equity of 86.72% and a negative net margin of 70.50%. The firm had revenue of $2.26 million for the quarter.

Hedge Funds Weigh In On Milestone Scientific

A hedge fund recently bought a new stake in Milestone Scientific stock. AE Wealth Management LLC purchased a new position in shares of Milestone Scientific Inc. (NYSE:MLSS) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 27,936 shares of the company’s stock, valued at approximately $26,000. 5.79% of the stock is currently owned by institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.